Other
Other Comprehensive Income (Loss), Net of Tax, Attributable to Parent
West Pharmaceutical Services Other Comprehensive Income (Loss), Net of Tax, Attributable to Parent decreased by 44.9% to -$19.70M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 137.5%, from $52.60M to -$19.70M.
Analysis
StatementIncome Statement
SectionOther
First reportedQ1 2019
Last reportedQ1 2026Apr 23, 2026
Metric ID:
vz_oci_net_of_tax_attributable_to_parentHistorical Data
15 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $7.00M | -$22.50M | -$22.80M | -$63.50M | -$62.60M | $14.60M | -$15.10M | -$39.50M | -$48.50M | -$24.60M | $80.60M | $52.60M | $116.80M | -$13.60M | -$19.70M |
| QoQ Change | — | -421.4% | -1.3% | -178.5% | +1.4% | +123.3% | -203.4% | -161.6% | -22.8% | +49.3% | +427.6% | -34.7% | +122.1% | -111.6% | -44.9% |
| YoY Change | — | — | — | <-999% | -178.2% | +164.0% | +76.2% | +36.9% | -432.2% | -62.9% | +304.1% | +208.5% | +574.8% | -116.9% | -137.5% |
Range-$63.50M – $116.80M
CAGR+34.4%
Avg YoY Growth-47.5%
Median YoY Growth-13.0%
Current Streak2 quarters decline
Other Comprehensive Income (Loss), Net of Tax, Attributable to Parent at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's other comprehensive income (loss), net of tax, attributable to parent?
- West Pharmaceutical Services (WST) reported other comprehensive income (loss), net of tax, attributable to parent of -$19.70M in Q1 2026.
- How has West Pharmaceutical Services's other comprehensive income (loss), net of tax, attributable to parent changed year-over-year?
- West Pharmaceutical Services's other comprehensive income (loss), net of tax, attributable to parent decreased by 137.5% year-over-year, from $52.60M to -$19.70M.